rs121912838

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PS3PM1PM5PP3_StrongPP5

The NM_000094.4(COL7A1):​c.6091G>A​(p.Gly2031Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000932 in 1,609,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV006322774: Relevant functional assessments of this variant are available in the literature (PMID:12228020).". Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G2031V) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000082 ( 0 hom. )

Consequence

COL7A1
NM_000094.4 missense

Scores

13
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7U:2

Conservation

PhyloP100: 7.55

Publications

10 publications found
Variant links:
Genes affected
COL7A1 (HGNC:2214): (collagen type VII alpha 1 chain) This gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen. [provided by RefSeq, Jul 2008]
COL7A1 Gene-Disease associations (from GenCC):
  • epidermolysis bullosa with congenital localized absence of skin and deformity of nails
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • dystrophic epidermolysis bullosa pruriginosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • recessive dystrophic epidermolysis bullosa
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Genomics England PanelApp, ClinGen
  • generalized dominant dystrophic epidermolysis bullosa
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • pretibial dystrophic epidermolysis bullosa
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • transient bullous dermolysis of the newborn
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • acral dystrophic epidermolysis bullosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dystrophic epidermolysis bullosa, nails only
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa inversa
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • recessive dystrophic epidermolysis bullosa-generalized other
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV006322774: Relevant functional assessments of this variant are available in the literature (PMID: 12228020).
PM1
In a hotspot region, there are 9 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000094.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-48575427-C-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2696524.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989
PP5
Variant 3-48575428-C-T is Pathogenic according to our data. Variant chr3-48575428-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 17446.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000094.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL7A1
NM_000094.4
MANE Select
c.6091G>Ap.Gly2031Ser
missense
Exon 74 of 119NP_000085.1Q02388-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL7A1
ENST00000681320.1
MANE Select
c.6091G>Ap.Gly2031Ser
missense
Exon 74 of 119ENSP00000506558.1Q02388-1
COL7A1
ENST00000328333.12
TSL:1
c.6091G>Ap.Gly2031Ser
missense
Exon 73 of 118ENSP00000332371.8Q02388-1
COL7A1
ENST00000487017.5
TSL:5
n.2008G>A
non_coding_transcript_exon
Exon 39 of 83

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152152
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000253
AC:
6
AN:
237354
AF XY:
0.0000307
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000619
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000823
AC:
12
AN:
1457548
Hom.:
0
Cov.:
39
AF XY:
0.00000828
AC XY:
6
AN XY:
725054
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33324
American (AMR)
AF:
0.00
AC:
0
AN:
44414
Ashkenazi Jewish (ASJ)
AF:
0.000461
AC:
12
AN:
26024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39622
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86112
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51342
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110826
Other (OTH)
AF:
0.00
AC:
0
AN:
60188
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152152
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41448
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.00000833
AC:
1

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Recessive dystrophic epidermolysis bullosa (3)
2
-
-
not provided (2)
1
1
-
Recessive dystrophic epidermolysis bullosa;C0268371:Dominant dystrophic epidermolysis bullosa with absence of skin;C0432321:Pretibial dystrophic epidermolysis bullosa;C0432322:Generalized dominant dystrophic epidermolysis bullosa;C1275114:Epidermolysis bullosa pruriginosa;C1843761:Nonsyndromic congenital nail disorder 8;C1851573:Transient bullous dermolysis of the newborn (2)
-
1
-
Duane retraction syndrome (1)
1
-
-
Epidermolysis bullosa dystrophica (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.55
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
29
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.80
D
Eigen
Pathogenic
0.94
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.71
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.2
H
PhyloP100
7.6
PrimateAI
Pathogenic
0.84
D
PROVEAN
Pathogenic
-4.5
D
REVEL
Pathogenic
0.95
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.91
Loss of glycosylation at P2027 (P = 0.0203)
MVP
0.98
MPC
0.25
ClinPred
0.97
D
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.67
gMVP
0.99
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121912838; hg19: chr3-48612861; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.